Mihály Cserepes

7PUBLICATIONS
21CO-AUTHORS
Molecular targetsCancer cell biologyNeurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 28, 2026
Importance of Patient-Derived Xenograft Models in Battling Cancer Therapy Resistance.

|Jul 29, 2023
Evolving Acquired Vemurafenib Resistance in a BRAF V600E Mutant Melanoma PDTX Model to Reveal New Potential Targets.

József Tóvári, Diána Vári-Mező, Sára Eszter Surguta

|Mar 11, 2023
Context-Dependent Role of Glucocorticoid Receptor Alpha and Beta in Breast Cancer Cell Behaviour.

Henriett Butz, Éva Saskői, Lilla Krokker

|Sep 23, 2022
A Novel C-Type Lectin Receptor-Targeted α-Synuclein-Based Parkinson Vaccine Induces Potent Immune Responses and Therapeutic Efficacy in Mice.

Sabine Schmidhuber, Sandra Scheiblhofer, Richard Weiss

|May 28, 2022
EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer.

Mihály Cserepes, Györgyi A Nelhűbel, Mónika Meilinger-Dobra

|May 17, 2020
P38 MAPK Promotes Migration and Metastatic Activity of BRAF Mutant Melanoma Cells by Inducing Degradation of PMCA4b.

Randa Naffa, Lisa Vogel, Luca Hegedűs

Pageof 2

Frequent Collaborators

3 joint publications

Andrea Ladányi

2 joint publications

Jozsef Tovari

1 joint publications

Dóra Türk

1 joint publications

Szilárd Tóth